share_log

Bellerophon Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Theodore Wang(0.5%),Puissance Life Science Opportunities Fund VI(0%), etc.

SEC announcement ·  Oct 16, 2023 20:56
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more